Technical Analysis for HROW - Harrow Health, Inc.

Grade Last Price % Change Price Change
D 7.3 8.31% 0.56
HROW closed up 8.31 percent on Thursday, April 15, 2021, on 1.37 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical HROW trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 8.31%
Down 3 Days in a Row Weakness 8.31%
Narrow Range Bar Range Contraction 7.67%
NR7 Range Contraction 7.67%
Inside Day Range Contraction 7.67%
20 DMA Resistance Bearish 6.10%
20 DMA Resistance Bearish 3.55%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.55%
Older End-of-Day Signals for HROW ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% about 10 hours ago
Possible Pocket Pivot about 10 hours ago
Up 1 ATR about 10 hours ago
10 DMA Support about 12 hours ago
60 Minute Opening Range Breakout about 12 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Harrow Health, Inc. Description

Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Infectious Diseases Pharmaceuticals Pharmacy Urology Ophthalmology Pharmaceutical Sciences Drug Therapies Compounding

Is HROW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.1
52 Week Low 3.75
Average Volume 186,450
200-Day Moving Average 6.59
50-Day Moving Average 7.89
20-Day Moving Average 6.88
10-Day Moving Average 6.88
Average True Range 0.42
ADX 22.89
+DI 21.60
-DI 20.50
Chandelier Exit (Long, 3 ATRs ) 6.74
Chandelier Exit (Short, 3 ATRs ) 7.26
Upper Bollinger Band 7.49
Lower Bollinger Band 6.28
Percent B (%b) 0.84
BandWidth 17.68
MACD Line -0.21
MACD Signal Line -0.30
MACD Histogram 0.0871
Fundamentals Value
Market Cap 187.95 Million
Num Shares 25.7 Million
EPS 0.58
Price-to-Earnings (P/E) Ratio 12.56
Price-to-Sales 3.17
Price-to-Book 5.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.09
Resistance 3 (R3) 8.02 7.68 7.96
Resistance 2 (R2) 7.68 7.48 7.72 7.91
Resistance 1 (R1) 7.49 7.36 7.59 7.56 7.87
Pivot Point 7.16 7.16 7.21 7.19 7.16
Support 1 (S1) 6.97 6.96 7.06 7.04 6.73
Support 2 (S2) 6.63 6.83 6.67 6.69
Support 3 (S3) 6.44 6.63 6.64
Support 4 (S4) 6.51